nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—ITGB3—epithelium—ovarian cancer	0.0344	0.156	CbGeAlD
Tirofiban—ITGB3—decidua—ovarian cancer	0.0325	0.147	CbGeAlD
Tirofiban—ITGA2B—bone marrow—ovarian cancer	0.0276	0.125	CbGeAlD
Tirofiban—ITGB3—female reproductive system—ovarian cancer	0.0256	0.116	CbGeAlD
Tirofiban—ITGB3—bone marrow—ovarian cancer	0.0241	0.109	CbGeAlD
Tirofiban—ITGA2B—testis—ovarian cancer	0.0236	0.107	CbGeAlD
Tirofiban—ITGB3—testis—ovarian cancer	0.0206	0.0936	CbGeAlD
Tirofiban—ITGA2B—lymph node—ovarian cancer	0.0171	0.0776	CbGeAlD
Tirofiban—ITGB3—lymph node—ovarian cancer	0.015	0.0678	CbGeAlD
Tirofiban—Thrombocytopenia—Altretamine—ovarian cancer	0.00406	0.0355	CcSEcCtD
Tirofiban—Haemoptysis—Paclitaxel—ovarian cancer	0.00286	0.025	CcSEcCtD
Tirofiban—Dizziness—Altretamine—ovarian cancer	0.00274	0.024	CcSEcCtD
Tirofiban—Haemoglobin decreased—Docetaxel—ovarian cancer	0.00261	0.0228	CcSEcCtD
Tirofiban—Nausea—Altretamine—ovarian cancer	0.00246	0.0215	CcSEcCtD
Tirofiban—Pain—Carboplatin—ovarian cancer	0.00245	0.0214	CcSEcCtD
Tirofiban—Body temperature increased—Carboplatin—ovarian cancer	0.00226	0.0198	CcSEcCtD
Tirofiban—Sweating—Topotecan—ovarian cancer	0.00197	0.0172	CcSEcCtD
Tirofiban—Haemoglobin—Topotecan—ovarian cancer	0.00186	0.0162	CcSEcCtD
Tirofiban—Haemorrhage—Topotecan—ovarian cancer	0.00185	0.0161	CcSEcCtD
Tirofiban—Haemoglobin—Melphalan—ovarian cancer	0.00182	0.0159	CcSEcCtD
Tirofiban—Haemorrhage—Melphalan—ovarian cancer	0.00181	0.0158	CcSEcCtD
Tirofiban—Haematemesis—Epirubicin—ovarian cancer	0.00174	0.0152	CcSEcCtD
Tirofiban—Swelling—Paclitaxel—ovarian cancer	0.00174	0.0152	CcSEcCtD
Tirofiban—Myocardial infarction—Vinorelbine—ovarian cancer	0.00172	0.0151	CcSEcCtD
Tirofiban—Chills—Topotecan—ovarian cancer	0.00166	0.0145	CcSEcCtD
Tirofiban—Haemoptysis—Epirubicin—ovarian cancer	0.00163	0.0143	CcSEcCtD
Tirofiban—Haematemesis—Doxorubicin—ovarian cancer	0.00161	0.0141	CcSEcCtD
Tirofiban—Haemoptysis—Doxorubicin—ovarian cancer	0.00151	0.0132	CcSEcCtD
Tirofiban—Swelling—Docetaxel—ovarian cancer	0.00148	0.0129	CcSEcCtD
Tirofiban—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00144	0.0126	CcSEcCtD
Tirofiban—Anaphylactic shock—Topotecan—ovarian cancer	0.00131	0.0115	CcSEcCtD
Tirofiban—Oedema—Melphalan—ovarian cancer	0.00128	0.0112	CcSEcCtD
Tirofiban—Anaphylactic shock—Melphalan—ovarian cancer	0.00128	0.0112	CcSEcCtD
Tirofiban—Thrombocytopenia—Topotecan—ovarian cancer	0.00128	0.0112	CcSEcCtD
Tirofiban—Hyperhidrosis—Topotecan—ovarian cancer	0.00127	0.0111	CcSEcCtD
Tirofiban—Pain—Chlorambucil—ovarian cancer	0.00126	0.011	CcSEcCtD
Tirofiban—Thrombocytopenia—Melphalan—ovarian cancer	0.00126	0.011	CcSEcCtD
Tirofiban—Hypertension—Vinorelbine—ovarian cancer	0.00119	0.0104	CcSEcCtD
Tirofiban—Urticaria—Chlorambucil—ovarian cancer	0.00117	0.0102	CcSEcCtD
Tirofiban—Body temperature increased—Chlorambucil—ovarian cancer	0.00116	0.0102	CcSEcCtD
Tirofiban—Myocardial infarction—Paclitaxel—ovarian cancer	0.00116	0.0101	CcSEcCtD
Tirofiban—Haematuria—Paclitaxel—ovarian cancer	0.00113	0.00986	CcSEcCtD
Tirofiban—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00112	0.0098	CcSEcCtD
Tirofiban—Pain—Topotecan—ovarian cancer	0.00112	0.0098	CcSEcCtD
Tirofiban—Thrombocytopenia—Vinorelbine—ovarian cancer	0.0011	0.0096	CcSEcCtD
Tirofiban—Pain—Melphalan—ovarian cancer	0.0011	0.0096	CcSEcCtD
Tirofiban—Hypersensitivity—Chlorambucil—ovarian cancer	0.00109	0.00948	CcSEcCtD
Tirofiban—Bradycardia—Paclitaxel—ovarian cancer	0.00108	0.00945	CcSEcCtD
Tirofiban—Haemoglobin—Paclitaxel—ovarian cancer	0.00107	0.00933	CcSEcCtD
Tirofiban—Haemorrhage—Paclitaxel—ovarian cancer	0.00106	0.00928	CcSEcCtD
Tirofiban—Urticaria—Topotecan—ovarian cancer	0.00104	0.0091	CcSEcCtD
Tirofiban—Body temperature increased—Topotecan—ovarian cancer	0.00104	0.00906	CcSEcCtD
Tirofiban—Urticaria—Melphalan—ovarian cancer	0.00102	0.00891	CcSEcCtD
Tirofiban—Myocardial infarction—Docetaxel—ovarian cancer	0.000983	0.00859	CcSEcCtD
Tirofiban—Hypersensitivity—Topotecan—ovarian cancer	0.000966	0.00844	CcSEcCtD
Tirofiban—Pain—Vinorelbine—ovarian cancer	0.00096	0.00838	CcSEcCtD
Tirofiban—Chills—Paclitaxel—ovarian cancer	0.000953	0.00833	CcSEcCtD
Tirofiban—Hypersensitivity—Melphalan—ovarian cancer	0.000946	0.00827	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—SOD1—ovarian cancer	0.000921	0.00138	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	0.000917	0.00138	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—PPP2R1A—ovarian cancer	0.000916	0.00138	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—MMP2—ovarian cancer	0.000915	0.00138	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—NRAS—ovarian cancer	0.000913	0.00137	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—CTNNB1—ovarian cancer	0.000912	0.00137	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—IL6ST—ovarian cancer	0.000912	0.00137	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	0.000912	0.00137	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—PIK3CD—ovarian cancer	0.000909	0.00137	CbGpPWpGaD
Tirofiban—Haemoglobin—Docetaxel—ovarian cancer	0.000905	0.00791	CcSEcCtD
Tirofiban—Haemorrhage—Docetaxel—ovarian cancer	0.0009	0.00787	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—ovarian cancer	0.000898	0.00135	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—DLC1—ovarian cancer	0.000894	0.00134	CbGpPWpGaD
Tirofiban—Urticaria—Vinorelbine—ovarian cancer	0.000891	0.00779	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—PTEN—ovarian cancer	0.000889	0.00134	CbGpPWpGaD
Tirofiban—Body temperature increased—Vinorelbine—ovarian cancer	0.000887	0.00775	CcSEcCtD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—KRAS—ovarian cancer	0.000886	0.00133	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—MAPK1—ovarian cancer	0.000881	0.00133	CbGpPWpGaD
Tirofiban—Nausea—Chlorambucil—ovarian cancer	0.000875	0.00765	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—MAPK3—ovarian cancer	0.000874	0.00131	CbGpPWpGaD
Tirofiban—Dizziness—Topotecan—ovarian cancer	0.000867	0.00758	CcSEcCtD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—AKT1—ovarian cancer	0.000858	0.00129	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—AKT1—ovarian cancer	0.000856	0.00129	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—STAT3—ovarian cancer	0.000856	0.00129	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—NRAS—ovarian cancer	0.000854	0.00128	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—IL2—ovarian cancer	0.000837	0.00126	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—KRAS—ovarian cancer	0.000833	0.00125	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—MAPK1—ovarian cancer	0.000832	0.00125	CbGpPWpGaD
Tirofiban—Hypersensitivity—Vinorelbine—ovarian cancer	0.000827	0.00722	CcSEcCtD
Tirofiban—Headache—Topotecan—ovarian cancer	0.000822	0.00718	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—MAPK3—ovarian cancer	0.000818	0.00123	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—PIK3CA—ovarian cancer	0.000814	0.00122	CbGpPWpGaD
Tirofiban—Chills—Docetaxel—ovarian cancer	0.000808	0.00706	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	0.000806	0.00121	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—ERBB2—ovarian cancer	0.000803	0.00121	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—VEGFA—ovarian cancer	0.000803	0.00121	CbGpPWpGaD
Tirofiban—Hypertension—Paclitaxel—ovarian cancer	0.000798	0.00698	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—MYC—ovarian cancer	0.000796	0.0012	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—PIK3CB—ovarian cancer	0.000793	0.00119	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—KRAS—ovarian cancer	0.000786	0.00118	CbGpPWpGaD
Tirofiban—Nausea—Topotecan—ovarian cancer	0.000779	0.00681	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—MAPK1—ovarian cancer	0.000778	0.00117	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—MMP2—ovarian cancer	0.000776	0.00117	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—PIK3CA—ovarian cancer	0.000765	0.00115	CbGpPWpGaD
Tirofiban—Nausea—Melphalan—ovarian cancer	0.000763	0.00666	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—MYC—ovarian cancer	0.000762	0.00115	CbGpPWpGaD
Tirofiban—Oedema—Paclitaxel—ovarian cancer	0.000755	0.00659	CcSEcCtD
Tirofiban—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000755	0.00659	CcSEcCtD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—HRAS—ovarian cancer	0.000753	0.00113	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—DOK1—ovarian cancer	0.000748	0.00112	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—HRAS—ovarian cancer	0.000747	0.00112	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—MAPK1—ovarian cancer	0.000745	0.00112	CbGpPWpGaD
Tirofiban—Dizziness—Vinorelbine—ovarian cancer	0.000742	0.00648	CcSEcCtD
Tirofiban—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000739	0.00646	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—KRAS—ovarian cancer	0.000735	0.00111	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—CDH1—ovarian cancer	0.000732	0.0011	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00073	0.00637	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—BCL9—ovarian cancer	0.000729	0.0011	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—CASP3—ovarian cancer	0.000727	0.00109	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—MAPK1—ovarian cancer	0.000723	0.00109	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—EGFR—ovarian cancer	0.000723	0.00109	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—PIK3CA—ovarian cancer	0.000722	0.00109	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MET—ovarian cancer	0.000717	0.00108	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	0.000712	0.00107	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—CCND1—ovarian cancer	0.00071	0.00107	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—SOD1—ovarian cancer	0.000709	0.00107	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—HRAS—ovarian cancer	0.000708	0.00106	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PPP2R1A—ovarian cancer	0.000706	0.00106	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—MMP2—ovarian cancer	0.000704	0.00106	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PPP1CC—ovarian cancer	0.000703	0.00106	CbGpPWpGaD
Tirofiban—Headache—Vinorelbine—ovarian cancer	0.000703	0.00614	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—CTNNB1—ovarian cancer	0.000703	0.00106	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—IL6ST—ovarian cancer	0.000702	0.00106	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	0.000702	0.00106	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—MMP9—ovarian cancer	0.000687	0.00103	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—PTEN—ovarian cancer	0.000685	0.00103	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—ERBB2—ovarian cancer	0.00068	0.00102	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—IL6—ovarian cancer	0.000677	0.00102	CbGpPWpGaD
Tirofiban—Hypertension—Docetaxel—ovarian cancer	0.000677	0.00591	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—PIK3CA—ovarian cancer	0.000675	0.00102	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—CAV1—ovarian cancer	0.000673	0.00101	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	0.000673	0.00101	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—HRAS—ovarian cancer	0.000668	0.001	CbGpPWpGaD
Tirofiban—Nausea—Vinorelbine—ovarian cancer	0.000667	0.00582	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—MET—ovarian cancer	0.000664	0.000999	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—AKT1—ovarian cancer	0.00066	0.000992	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—IL6ST—ovarian cancer	0.000651	0.000978	CbGpPWpGaD
Tirofiban—Sweating—Epirubicin—ovarian cancer	0.000649	0.00567	CcSEcCtD
Tirofiban—Pain—Paclitaxel—ovarian cancer	0.000645	0.00564	CcSEcCtD
Tirofiban—Haematuria—Epirubicin—ovarian cancer	0.000645	0.00564	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—IL2—ovarian cancer	0.000645	0.00097	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	0.00064	0.000963	CbGpPWpGaD
Tirofiban—Oedema—Docetaxel—ovarian cancer	0.00064	0.00559	CcSEcCtD
Tirofiban—Anaphylactic shock—Docetaxel—ovarian cancer	0.00064	0.00559	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—IL6—ovarian cancer	0.000639	0.000961	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—PIK3CA—ovarian cancer	0.000627	0.000943	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Docetaxel—ovarian cancer	0.000626	0.00547	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TP53—ovarian cancer	0.000626	0.000941	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—HRAS—ovarian cancer	0.000625	0.00094	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—AKT1—ovarian cancer	0.000625	0.00094	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—VEGFA—ovarian cancer	0.000619	0.00093	CbGpPWpGaD
Tirofiban—Bradycardia—Epirubicin—ovarian cancer	0.000618	0.0054	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—PIK3CG—ovarian cancer	0.000613	0.000922	CbGpPWpGaD
Tirofiban—Haemoglobin—Epirubicin—ovarian cancer	0.00061	0.00533	CcSEcCtD
Tirofiban—Haemorrhage—Epirubicin—ovarian cancer	0.000607	0.00531	CcSEcCtD
Tirofiban—Sweating—Doxorubicin—ovarian cancer	0.0006	0.00524	CcSEcCtD
Tirofiban—Urticaria—Paclitaxel—ovarian cancer	0.0006	0.00524	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—MMP2—ovarian cancer	0.000598	0.000899	CbGpPWpGaD
Tirofiban—Haematuria—Doxorubicin—ovarian cancer	0.000597	0.00521	CcSEcCtD
Tirofiban—Body temperature increased—Paclitaxel—ovarian cancer	0.000597	0.00521	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—AKT1—ovarian cancer	0.00059	0.000887	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—MMP9—ovarian cancer	0.000583	0.000877	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—HRAS—ovarian cancer	0.00058	0.000873	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—DOK1—ovarian cancer	0.000576	0.000867	CbGpPWpGaD
Tirofiban—Bradycardia—Doxorubicin—ovarian cancer	0.000572	0.005	CcSEcCtD
Tirofiban—Haemoglobin—Doxorubicin—ovarian cancer	0.000565	0.00493	CcSEcCtD
Tirofiban—Haemorrhage—Doxorubicin—ovarian cancer	0.000562	0.00491	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—CASP3—ovarian cancer	0.00056	0.000843	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—MAPK1—ovarian cancer	0.000557	0.000837	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—EGFR—ovarian cancer	0.000557	0.000837	CbGpPWpGaD
Tirofiban—Hypersensitivity—Paclitaxel—ovarian cancer	0.000556	0.00486	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	0.000556	0.000836	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MMP2—ovarian cancer	0.000554	0.000833	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	0.000548	0.000824	CbGpPWpGaD
Tirofiban—Pain—Docetaxel—ovarian cancer	0.000547	0.00478	CcSEcCtD
Tirofiban—Chills—Epirubicin—ovarian cancer	0.000545	0.00476	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—PPP1CC—ovarian cancer	0.000542	0.000815	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—PIK3CD—ovarian cancer	0.000539	0.000811	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HDAC6—ovarian cancer	0.000533	0.000802	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—MMP9—ovarian cancer	0.000529	0.000796	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—AKT1—ovarian cancer	0.000528	0.000794	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—ERBB2—ovarian cancer	0.000524	0.000788	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—VEGFA—ovarian cancer	0.000524	0.000788	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—CAV1—ovarian cancer	0.000519	0.00078	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	0.000519	0.00078	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—NRAS—ovarian cancer	0.000518	0.000778	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—AKT1—ovarian cancer	0.000512	0.00077	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MET—ovarian cancer	0.000512	0.000769	CbGpPWpGaD
Tirofiban—Body temperature increased—Docetaxel—ovarian cancer	0.000506	0.00442	CcSEcCtD
Tirofiban—Chills—Doxorubicin—ovarian cancer	0.000504	0.0044	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—IL6ST—ovarian cancer	0.000501	0.000754	CbGpPWpGaD
Tirofiban—Dizziness—Paclitaxel—ovarian cancer	0.000499	0.00436	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—MAPK3—ovarian cancer	0.000496	0.000745	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	0.000493	0.000742	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—ERBB2—ovarian cancer	0.000485	0.00073	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—PIK3CA—ovarian cancer	0.000483	0.000727	CbGpPWpGaD
Tirofiban—Headache—Paclitaxel—ovarian cancer	0.000473	0.00413	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—PIK3CG—ovarian cancer	0.000472	0.00071	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—YAP1—ovarian cancer	0.000472	0.000709	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—MAPK1—ovarian cancer	0.000472	0.000709	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—EGFR—ovarian cancer	0.000472	0.000709	CbGpPWpGaD
Tirofiban—Hypersensitivity—Docetaxel—ovarian cancer	0.000471	0.00412	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—PIK3CB—ovarian cancer	0.00047	0.000707	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—XIAP—ovarian cancer	0.000462	0.000695	CbGpPWpGaD
Tirofiban—Hypertension—Epirubicin—ovarian cancer	0.000456	0.00399	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	0.000454	0.000683	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SMARCA4—ovarian cancer	0.00045	0.000677	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MMP9—ovarian cancer	0.000449	0.000676	CbGpPWpGaD
Tirofiban—Nausea—Paclitaxel—ovarian cancer	0.000448	0.00392	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—HRAS—ovarian cancer	0.000447	0.000672	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—KRAS—ovarian cancer	0.000445	0.00067	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EREG—ovarian cancer	0.00044	0.000661	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—IL2—ovarian cancer	0.000432	0.000649	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Epirubicin—ovarian cancer	0.000431	0.00377	CcSEcCtD
Tirofiban—Oedema—Epirubicin—ovarian cancer	0.000431	0.00377	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	0.000428	0.000644	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MMP2—ovarian cancer	0.000427	0.000642	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—CTNNB1—ovarian cancer	0.000425	0.000639	CbGpPWpGaD
Tirofiban—Dizziness—Docetaxel—ovarian cancer	0.000423	0.0037	CcSEcCtD
Tirofiban—Thrombocytopenia—Epirubicin—ovarian cancer	0.000422	0.00369	CcSEcCtD
Tirofiban—Hypertension—Doxorubicin—ovarian cancer	0.000422	0.00369	CcSEcCtD
Tirofiban—Hyperhidrosis—Epirubicin—ovarian cancer	0.000417	0.00364	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—MMP9—ovarian cancer	0.000416	0.000626	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PIK3CD—ovarian cancer	0.000415	0.000625	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PGR—ovarian cancer	0.000412	0.000619	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HDAC6—ovarian cancer	0.000411	0.000617	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—VEGFA—ovarian cancer	0.000404	0.000607	CbGpPWpGaD
Tirofiban—Headache—Docetaxel—ovarian cancer	0.000401	0.0035	CcSEcCtD
Tirofiban—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000399	0.00349	CcSEcCtD
Tirofiban—Oedema—Doxorubicin—ovarian cancer	0.000399	0.00349	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—NRAS—ovarian cancer	0.000399	0.000599	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—AKT1—ovarian cancer	0.000395	0.000594	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000391	0.00341	CcSEcCtD
Tirofiban—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000386	0.00337	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—PARP1—ovarian cancer	0.000383	0.000576	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MAPK3—ovarian cancer	0.000382	0.000574	CbGpPWpGaD
Tirofiban—Nausea—Docetaxel—ovarian cancer	0.00038	0.00332	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—HRAS—ovarian cancer	0.000379	0.000569	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—ERBB2—ovarian cancer	0.000374	0.000562	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—VEGFA—ovarian cancer	0.000374	0.000562	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—STAT3—ovarian cancer	0.00037	0.000557	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—NRAS—ovarian cancer	0.000369	0.000555	CbGpPWpGaD
Tirofiban—Pain—Epirubicin—ovarian cancer	0.000369	0.00322	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—VEGFA—ovarian cancer	0.000367	0.000552	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—YAP1—ovarian cancer	0.000363	0.000546	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MAPK1—ovarian cancer	0.000363	0.000546	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—EGFR—ovarian cancer	0.000363	0.000546	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—IL6—ovarian cancer	0.000362	0.000545	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—NRAS—ovarian cancer	0.000362	0.000545	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PIK3CB—ovarian cancer	0.000362	0.000544	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—XIAP—ovarian cancer	0.000356	0.000535	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MAPK3—ovarian cancer	0.000354	0.000532	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	0.00035	0.000526	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—MAPK3—ovarian cancer	0.000347	0.000522	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SMARCA4—ovarian cancer	0.000347	0.000522	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—KRAS—ovarian cancer	0.000343	0.000516	CbGpPWpGaD
Tirofiban—Urticaria—Epirubicin—ovarian cancer	0.000343	0.00299	CcSEcCtD
Tirofiban—Pain—Doxorubicin—ovarian cancer	0.000341	0.00298	CcSEcCtD
Tirofiban—Body temperature increased—Epirubicin—ovarian cancer	0.000341	0.00298	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—EREG—ovarian cancer	0.000339	0.000509	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MAPK1—ovarian cancer	0.000337	0.000506	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—EGFR—ovarian cancer	0.000336	0.000506	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IL2—ovarian cancer	0.000332	0.0005	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—MAPK1—ovarian cancer	0.00033	0.000496	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—CTNNB1—ovarian cancer	0.000327	0.000492	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MMP9—ovarian cancer	0.000321	0.000482	CbGpPWpGaD
Tirofiban—Hypersensitivity—Epirubicin—ovarian cancer	0.000318	0.00278	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—KRAS—ovarian cancer	0.000318	0.000478	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PGR—ovarian cancer	0.000317	0.000477	CbGpPWpGaD
Tirofiban—Urticaria—Doxorubicin—ovarian cancer	0.000317	0.00277	CcSEcCtD
Tirofiban—Body temperature increased—Doxorubicin—ovarian cancer	0.000316	0.00276	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—KRAS—ovarian cancer	0.000312	0.000469	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PPP2R1A—ovarian cancer	0.000311	0.000467	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PARP1—ovarian cancer	0.000295	0.000444	CbGpPWpGaD
Tirofiban—Hypersensitivity—Doxorubicin—ovarian cancer	0.000294	0.00257	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—HRAS—ovarian cancer	0.000292	0.000439	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—VEGFA—ovarian cancer	0.000288	0.000433	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—PIK3CA—ovarian cancer	0.000286	0.000431	CbGpPWpGaD
Tirofiban—Dizziness—Epirubicin—ovarian cancer	0.000285	0.00249	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—STAT3—ovarian cancer	0.000285	0.000429	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—NRAS—ovarian cancer	0.000284	0.000428	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—VEGFA—ovarian cancer	0.000283	0.000425	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—IL6—ovarian cancer	0.000279	0.00042	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—NRAS—ovarian cancer	0.000279	0.00042	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TP53—ovarian cancer	0.000277	0.000417	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MAPK3—ovarian cancer	0.000272	0.00041	CbGpPWpGaD
Tirofiban—Headache—Epirubicin—ovarian cancer	0.00027	0.00236	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—HRAS—ovarian cancer	0.00027	0.000406	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—MAPK3—ovarian cancer	0.000267	0.000402	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—HRAS—ovarian cancer	0.000265	0.000399	CbGpPWpGaD
Tirofiban—Dizziness—Doxorubicin—ovarian cancer	0.000264	0.00231	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—MAPK1—ovarian cancer	0.000259	0.00039	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—EGFR—ovarian cancer	0.000259	0.00039	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—IL6—ovarian cancer	0.000259	0.000389	CbGpPWpGaD
Tirofiban—Nausea—Epirubicin—ovarian cancer	0.000256	0.00224	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—MAPK1—ovarian cancer	0.000254	0.000382	CbGpPWpGaD
Tirofiban—Headache—Doxorubicin—ovarian cancer	0.00025	0.00219	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—TERT—ovarian cancer	0.000247	0.000371	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—KRAS—ovarian cancer	0.000245	0.000368	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—KRAS—ovarian cancer	0.00024	0.000361	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PPP2R1A—ovarian cancer	0.000239	0.00036	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—AKT1—ovarian cancer	0.000239	0.000359	CbGpPWpGaD
Tirofiban—Nausea—Doxorubicin—ovarian cancer	0.000237	0.00207	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—AKT1—ovarian cancer	0.000234	0.000352	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CAV1—ovarian cancer	0.000228	0.000343	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PIK3CA—ovarian cancer	0.000221	0.000332	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ESR1—ovarian cancer	0.00022	0.000331	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL6ST—ovarian cancer	0.000216	0.000325	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TP53—ovarian cancer	0.000213	0.000321	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—HRAS—ovarian cancer	0.000208	0.000313	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—APC—ovarian cancer	0.000208	0.000313	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CG—ovarian cancer	0.000208	0.000313	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—HRAS—ovarian cancer	0.000204	0.000307	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—IL6—ovarian cancer	0.000199	0.0003	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TERT—ovarian cancer	0.00019	0.000286	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—AKT1—ovarian cancer	0.000184	0.000276	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CD—ovarian cancer	0.000183	0.000275	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—AKT1—ovarian cancer	0.00018	0.000271	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CAV1—ovarian cancer	0.000176	0.000264	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ESR1—ovarian cancer	0.000169	0.000255	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL6ST—ovarian cancer	0.000167	0.000251	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ERBB2—ovarian cancer	0.000161	0.000243	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—APC—ovarian cancer	0.00016	0.000241	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CG—ovarian cancer	0.00016	0.000241	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CB—ovarian cancer	0.000159	0.00024	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MTOR—ovarian cancer	0.000159	0.00024	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCL8—ovarian cancer	0.000153	0.00023	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CDKN1B—ovarian cancer	0.00015	0.000225	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CASP3—ovarian cancer	0.000147	0.00022	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL2—ovarian cancer	0.000146	0.00022	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCND1—ovarian cancer	0.000143	0.000214	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CTNNB1—ovarian cancer	0.000141	0.000212	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CD—ovarian cancer	0.000141	0.000212	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MMP9—ovarian cancer	0.000138	0.000208	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTEN—ovarian cancer	0.000138	0.000207	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ERBB2—ovarian cancer	0.000124	0.000187	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—VEGFA—ovarian cancer	0.000124	0.000187	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—STAT3—ovarian cancer	0.000123	0.000185	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NRAS—ovarian cancer	0.000123	0.000185	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CB—ovarian cancer	0.000123	0.000185	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MTOR—ovarian cancer	0.000123	0.000185	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCL8—ovarian cancer	0.000118	0.000177	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MAPK3—ovarian cancer	0.000118	0.000177	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDKN1B—ovarian cancer	0.000115	0.000173	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MYC—ovarian cancer	0.000114	0.000172	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CASP3—ovarian cancer	0.000113	0.00017	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL2—ovarian cancer	0.000113	0.000169	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MAPK1—ovarian cancer	0.000112	0.000168	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EGFR—ovarian cancer	0.000112	0.000168	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCND1—ovarian cancer	0.00011	0.000165	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CTNNB1—ovarian cancer	0.000109	0.000164	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MMP9—ovarian cancer	0.000107	0.00016	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTEN—ovarian cancer	0.000106	0.000159	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KRAS—ovarian cancer	0.000106	0.000159	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CA—ovarian cancer	9.71e-05	0.000146	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—VEGFA—ovarian cancer	9.58e-05	0.000144	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—STAT3—ovarian cancer	9.48e-05	0.000143	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NRAS—ovarian cancer	9.46e-05	0.000142	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TP53—ovarian cancer	9.4e-05	0.000141	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MAPK3—ovarian cancer	9.06e-05	0.000136	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HRAS—ovarian cancer	8.99e-05	0.000135	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MYC—ovarian cancer	8.81e-05	0.000133	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MAPK1—ovarian cancer	8.62e-05	0.00013	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EGFR—ovarian cancer	8.62e-05	0.00013	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL6—ovarian cancer	8.6e-05	0.000129	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KRAS—ovarian cancer	8.14e-05	0.000122	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—AKT1—ovarian cancer	7.93e-05	0.000119	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CA—ovarian cancer	7.48e-05	0.000113	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TP53—ovarian cancer	7.24e-05	0.000109	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HRAS—ovarian cancer	6.92e-05	0.000104	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL6—ovarian cancer	6.62e-05	9.96e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AKT1—ovarian cancer	6.11e-05	9.19e-05	CbGpPWpGaD
